Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANTI-THYMOCYTE GLOBULIN (RABBIT)
- Avatrombopag Combined With IST as First-line Treatment for SAA
- Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation
- Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
- Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
- A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT)
- A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
- Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
- Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
- Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Everolimus Monotherapy as Immunosuppression After Liver Transplant
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- Envarsus XL Immunosuppression Following Liver Transplantation
- ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center
- Cardiac Safe Transplants for Systemic Sclerosis
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
- Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
- A Blood Stem Cell Transplant for Sickle Cell Disease
- Autologous Stem Cell Transplant for Crohn's Disease
- ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
- Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
- Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects
- ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA
- Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
- Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
- Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
- A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
- Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
- Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
- Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
- Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
- Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
- Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
- MMF vs. AZA for Kidney Transplantation
- Thymoglobulin (ATG) Dose Finding Study
- Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
- Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
- Hematopoietic Stem Cell Support in Vasculitis
- Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
- Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
- Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
- Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
Clinical trials list
click for details